ECSP003580A - NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8 - Google Patents

NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8

Info

Publication number
ECSP003580A
ECSP003580A ECSP003580A ECSP003580A EC SP003580 A ECSP003580 A EC SP003580A EC SP003580 A ECSP003580 A EC SP003580A EC SP003580 A ECSP003580 A EC SP003580A
Authority
EC
Ecuador
Prior art keywords
gdf
methods
analogs
vaccination
homologous
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Torben Halkier
Soeren Mouritsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003580 priority Critical patent/ECSP003580A/en
Publication of ECSP003580A publication Critical patent/ECSP003580A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se revelan métodos nuevos para aumentar la masa muscular mediante la inmunización contra el factor de diferenciación de crecimiento 8 (GDF-8, miostatina). La inmunización se efectua preferentemente mediante la administración de análogos de GDF-8 capaces de inducir la producción de anticuerpos contra GDF-8 homólogos. Se prefiere especialmente como un inmunógeno el GDF-8 homólogo modificado por la introducción de un solo o varios, epitopes de célula T extraños inmunodominantes y promiscuos a la vez que se conserva sustancialmente la estructura terciaria del GDF-8 homólogo. También se presenta la vacunación de ácido nucleico contra GDF-8 y la vacunación usando vacunas vivas, como asi también métodos y medios útiles para la vacunación. Dichos métodos y medios incluyen métodos para la identificación de análogos de GDF-8 inmunogénicos, métodos para la preparación de análogos de GDF-8 inmunogénicos, métodos para la preparación de análogos y formulaciones farmacéuticas como asi también fragmentos de ácido nucleico, vectores, células transformadas polipéptidos y formulaciones farmacéuticas.Novel methods of increasing muscle mass are revealed by immunization against growth differentiation factor 8 (GDF-8, myostatin). Immunization is preferably effected by administration of GDF-8 analogs capable of inducing the production of antibodies against homologous GDF-8. Especially preferred as an immunogen is homologous GDF-8 modified by the introduction of one or more, immunodominant and promiscuous foreign T-cell epitopes while substantially conserving the tertiary structure of the homologous GDF-8. Nucleic acid vaccination against GDF-8 and vaccination using live vaccines are also presented, as well as useful methods and means for vaccination. Such methods and means include methods for the identification of immunogenic GDF-8 analogs, methods for the preparation of immunogenic GDF-8 analogs, methods for the preparation of analogues and pharmaceutical formulations as well as nucleic acid fragments, vectors, transformed cells. polypeptides and pharmaceutical formulations.

ECSP003580 2000-07-20 2000-07-20 NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8 ECSP003580A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003580 ECSP003580A (en) 2000-07-20 2000-07-20 NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003580 ECSP003580A (en) 2000-07-20 2000-07-20 NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8

Publications (1)

Publication Number Publication Date
ECSP003580A true ECSP003580A (en) 2000-10-24

Family

ID=42041192

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003580 ECSP003580A (en) 2000-07-20 2000-07-20 NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8

Country Status (1)

Country Link
EC (1) ECSP003580A (en)

Similar Documents

Publication Publication Date Title
WO2001005820A3 (en) Method for down-regulating gdf-8 activity
GC0000355A (en) Novel method for down-regulation of amyloid
BR0212047A (en) Use of immunogen, polyamino or conjugate, immunogenic composition, nucleic acid fragment, vector, transformed cell, composition to induce amyloid antibody production, and stable cell line
Shirley et al. The biology of avian Eimeria with an emphasis on their control by vaccination
Du et al. Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens
US5500366A (en) Polynucleotide encoding T-cell epitopes of the protein TraT
Conlan et al. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes
Zadeh-Vakili et al. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
Baker et al. Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
HUE030655T2 (en) Compositions and methods of enhancing immune responses to eimeria
Xu et al. Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickens
US20220281907A1 (en) Modified hexa-acylated neisserial LPS
Girard et al. Flagellin produced in plants is a potent adjuvant for oral immunization
NO20051779L (en) Immunization against autologous ghrelin
TW201925240A (en) Peptide conjugates, conjugation process, and uses thereof
ES2375053T3 (en) PEPTIDE DERIVED FROM INTERLEUCINE-1-BETA AND ITS THERAPEUTIC APPLICATION.
ECSP003580A (en) NEW METHODS TO INCREASE MUSCLE MASS THROUGH IMMUNIZATION AGAINST GDF-8
AR024808A1 (en) METHOD TO INCREASE THE MUSCLE MASS THROUGH IMMUNIZATION AGAINST THE GROWTH DIFFERENTIATION FACTOR 8 (GDF-8, MIOSTATIN)
Xu et al. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera
US11389520B2 (en) Modified tetra-acylated neisserial LPS
Lundén et al. Iscoms in parasitological research
Rafqi et al. Immunization of Chicken with Live Eimeria tenella Sporulated Oocysts for Control of Caecal Coccidiosis
KR102154572B1 (en) Novel composition for BCG prime booster vaccine comprising Rv3628/Rv0351
ES2336684T3 (en) ORNITHOBACTERIUM RHINOTRACHEALE SUBUNITIES VACCINES.
WO2022055375A1 (en) Recombinant live vaccine for sars-cov-2 based on recombinant salmonella enteritidis